PT2727912T - Cristais de derivado de glicina e seu uso farmacêutico - Google Patents

Cristais de derivado de glicina e seu uso farmacêutico

Info

Publication number
PT2727912T
PT2727912T PT128044658T PT12804465T PT2727912T PT 2727912 T PT2727912 T PT 2727912T PT 128044658 T PT128044658 T PT 128044658T PT 12804465 T PT12804465 T PT 12804465T PT 2727912 T PT2727912 T PT 2727912T
Authority
PT
Portugal
Prior art keywords
crystals
pharmaceutical use
glycine derivative
glycine
derivative
Prior art date
Application number
PT128044658T
Other languages
English (en)
Inventor
Motohiro Shiraki
Takahashi Hirozumi
Nogami Tsutomu
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of PT2727912T publication Critical patent/PT2727912T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PT128044658T 2011-06-30 2012-06-29 Cristais de derivado de glicina e seu uso farmacêutico PT2727912T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011145446 2011-06-30

Publications (1)

Publication Number Publication Date
PT2727912T true PT2727912T (pt) 2017-07-25

Family

ID=47424249

Family Applications (1)

Application Number Title Priority Date Filing Date
PT128044658T PT2727912T (pt) 2011-06-30 2012-06-29 Cristais de derivado de glicina e seu uso farmacêutico

Country Status (13)

Country Link
US (1) US9006434B2 (pt)
EP (1) EP2727912B1 (pt)
JP (1) JP5998933B2 (pt)
KR (1) KR20140027944A (pt)
CN (1) CN103619823B (pt)
AU (1) AU2012276650B2 (pt)
CA (1) CA2837453C (pt)
DK (1) DK2727912T3 (pt)
ES (1) ES2633179T3 (pt)
PL (1) PL2727912T3 (pt)
PT (1) PT2727912T (pt)
UA (1) UA111213C2 (pt)
WO (1) WO2013002364A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2014051056A1 (ja) * 2012-09-28 2016-08-22 東レ株式会社 グリシン誘導体の結晶及びその医薬用途
JP7233829B2 (ja) 2016-12-27 2023-03-07 東京製綱株式会社 鋼管杭式土砂崩壊予防施設及び鋼管杭式土砂崩壊予防施設の形成方法
JP7337724B2 (ja) 2020-02-14 2023-09-04 大成建設株式会社 半地下タンク構造

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63968A (en) 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
NZ501589A (en) * 1997-07-02 2001-10-26 Merck & Co Inc Polymorphic form of tachykinin receptor antagonist 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,4H-1,2,4,-triazolo)methylmorpholine
US7566724B2 (en) * 2004-12-24 2009-07-28 Toray Industries, Inc. Glycine derivative and use thereof
JP5115478B2 (ja) 2006-06-14 2013-01-09 東レ株式会社 アレルギー性皮膚炎の治療又は予防剤
KR101423347B1 (ko) 2006-06-19 2014-07-24 도레이 카부시키가이샤 다발성 경화증의 치료 또는 예방제
AU2007262083B2 (en) 2006-06-20 2012-01-19 Toray Industries, Inc. Therapeutic or prophylactic agent for leukemia
JPWO2014051056A1 (ja) * 2012-09-28 2016-08-22 東レ株式会社 グリシン誘導体の結晶及びその医薬用途

Also Published As

Publication number Publication date
CA2837453A1 (en) 2013-01-03
JPWO2013002364A1 (ja) 2015-02-23
EP2727912B1 (en) 2017-04-19
JP5998933B2 (ja) 2016-09-28
EP2727912A1 (en) 2014-05-07
CA2837453C (en) 2017-04-11
WO2013002364A1 (ja) 2013-01-03
US9006434B2 (en) 2015-04-14
DK2727912T3 (en) 2017-07-17
CN103619823B (zh) 2016-01-20
PL2727912T3 (pl) 2017-12-29
ES2633179T3 (es) 2017-09-19
CN103619823A (zh) 2014-03-05
KR20140027944A (ko) 2014-03-07
AU2012276650A1 (en) 2014-01-23
EP2727912A4 (en) 2014-12-10
UA111213C2 (uk) 2016-04-11
US20140128605A1 (en) 2014-05-08
AU2012276650B2 (en) 2016-06-23

Similar Documents

Publication Publication Date Title
HK1258536A1 (zh) 用於誘導組織再生的肽及其應用
HK1215948A1 (zh) 醯胺及其醫藥用途
HK1199892A1 (en) Modified mini-hepcidin peptides and methods of using thereof
LT2683731T (lt) C4-monometiltriterpenoido dariniai ir jų panaudojimo būdai
IL228925A0 (en) Benzothiazole compounds and their pharmaceutical use
EP2739144A4 (en) COMPOUNDS AND ITS THERAPEUTIC USE
EP2788020A4 (en) THERAPEUTIC USE OF ANTI-CD22 ANTIBODIES FOR THE INDUCTION OF TROGO CYTOSIS
EP2772483A4 (en) 4-AMINOCARBAZOLE COMPOUND AND USE THEREOF
ZA201401653B (en) Pyrazol-4yl-heterocyclyl-carboxamide compounds and methods of use
ZA201401071B (en) Pyrazole compound and pharmaceutical use thereof
EP2718283A4 (en) INDAZOLE AND PYRROLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
EP2709999A4 (en) QUINAZOLINE-7-ETHER COMPOUNDS AND METHODS OF USE
PT2727912T (pt) Cristais de derivado de glicina e seu uso farmacêutico
GB201112578D0 (en) Pharmaceutical preparation and use
HUE043268T2 (hu) Pirazolvegyületek és azok gyógyászati alkalmazása
GB201104632D0 (en) Use of medicament